A recent review article highlights evolving MS-based methodologies that are reshaping ligand discovery and mechanistic characterization for membrane protein drug targets. LCGC International spoke to ...

Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal ...

Belite Bio (BLTE) stock outlook: tinlarebant clinical data, 2026 filings, key FDA/EU risks, and $165/share valuation. See if ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 9 includes Target Corp., The Trade Desk, UFP ...

A new Opportunity Snapshot commissioned by Orange Logic, and conducted by Forrester Consulting, reveals that Digital Asset Management (DAM) is undergoing a fundamental transformation from being ...

In a city where power is usually measured in votes and committee assignments, a single real estate deal just reset the ...

Detailed price information for Acrivon Therapeutics Inc (ACRV-Q) from The Globe and Mail including charting and trades.

Skyhawk Therapeutics shared results for SKY-0515, a drug designed to lower huntingtin. The drug appeared generally safe, with 60% reduction of huntingtin in blood at the highest dose tested. This data ...

A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled “A combination of differential expression and network connectivity analyses ...